Cambridge Investment Research Advisors
LMAT icon

Cambridge Investment Research Advisors’s LeMaitre Vascular LMAT Stock Holding History

Cambridge Investment Research Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-13,957
Closed -$522K – 2132
2017
Q3 		$522K Buy
+13,957
New +$475K 0.01% 1233

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Cambridge Investment Research Advisors's LMAT Position: Q4 2017 in Review

Cambridge Investment Research Advisors sold out of LeMaitre Vascular (LMAT) in Q4 2017, closing a stake of 13,957 shares — an estimated $522K sold.

Cambridge Investment Research Advisors first reported a position in LMAT in Q3 2017 and held it in 1 quarter. The position peaked at $522K in Q3 2017. 142 funds tracked by Wall St. Rank hold LMAT as of Q4 2017.

  • Cambridge Investment Research Advisors reported no remaining LeMaitre Vascular position as of Q4 2017 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 13,957 LeMaitre Vascular shares in Q4 2017, an estimated $522K.
  • Cambridge Investment Research Advisors first reported a position in LeMaitre Vascular in Q3 2017 and held it in 1 quarter.
  • Cambridge Investment Research Advisors's LeMaitre Vascular position peaked at $522K in Q3 2017.
  • 142 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2017.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2017, filed 22 Feb 2018.